CVS Health
CVS
#261
Rank
$78.38 B
Marketcap
$61.96
Share price
-2.12%
Change (1 day)
3.42%
Change (1 year)

P/E ratio for CVS Health (CVS)

P/E ratio as of July 2025 (TTM): 14.8

According to CVS Health's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 14.7793. At the end of 2024 the company had a P/E ratio of 12.2.

P/E ratio history for CVS Health from 2001 to 2025

PE ratio at the end of each year

Year P/E ratio Change
202412.20.54%
202312.2-57.31%
202228.565.75%
202117.237.95%
202012.5-14.61%
201914.6-112.25%
2018-119-1164.75%
201711.2-29.96%
201616.0-23.7%
201520.9
201318.920.22%
201215.7

P/E ratio for similar companies or competitors

Company P/E ratio P/E ratio differencediff. Country
1-800-PetMeds
PETS
20.4 38.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Rite Aid
RAD
-0.0219-100.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Walgreens Boots Alliance
WBA
-1.58-110.66%๐Ÿ‡บ๐Ÿ‡ธ USA

How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.